Eye-Mail® News Brief

The Eye-Mail® News Brief, in partnership with Primary Care Optometry News (PCON), is a highly informative e-news brief that delivers the most relevant content to the inboxes of the Academy members once a month. The Eye-Mail® News Brief includes articles on optometry, vision technology, trends in eye care, and even more.

November Issue

Statin therapy linked to decreased risk of diabetic retinopathy

WU, MARK_3
Perspective: Harry Green, OD, PhD, FAAO

Further investigation is needed before clinicians can be confident in the utility of statins as adjunct therapy for type 2 diabetes. Read more...

HbA1c a major risk factor in retinopathy progression

Kelly Malloy
Perspective: Kyle Sandberg, OD, FAAO
 
This study also highlights other important factors that should influence the clinical evaluation of our type 1 diabetics, including blood pressure, albumin excretion rates and cholesterol levels. Read more...

Patients with diabetes seldom need treatment 2 years after uneventful retinal screening

Brad Sutton
Perspective: Mark Swanson, OD, FAAO

Multiple studies show for those with no or minimal retinopathy the risk is low, regardless of screening method. Read more...

OCT changes minimally related to visual acuity variation

Mazzarella.Jarett.prof.photo.edit
Perspective: Jarett A. Mazzarella, OD, FAAO

The clinical take-home from this study is that SD-OCT central subfield thickness changes are not a reliable surrogate for visual outcomes after anti-VEGF therapy for diabetic macular edema. Read more...

Featured in OVS: Arteriole tortuosity associated with diabetic retinopathy and cholesterol


Earlier identification of diabetic eye disease is an important research effort. Retinopathy is widely acknowledged, but retinal vessel changes are not evaluated as stringently. This model shows an association between vessel changes, diabetic retinopathy and systemic cholesterol levels, indicating that patients with retinal vessel tortuosity may warrant further follow-up on health factors, such as cholesterol levels. – Weiler DL, Engelke CB, Moore AL, Harrison WW Read more...
DISCLAIMER
The Academy does not specifically endorse the studies contained within this brief. Rather, we serve as a conduit for sharing information on new/interesting topics that our membership might wish to explore further.